ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
OptimizeRx Corporation

OptimizeRx Corporation (OPRX)

5.11
-0.20
(-3.77%)
마감 27 2월 6:00AM
5.11
0.01
(0.20%)
시간외 거래: 8:24AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
5.11
매수가
5.05
매도가
6.55
거래량
88,314
5.0101 일간 변동폭 5.385
3.78 52주 범위 16.645
market_cap
전일 종가
5.31
개장가
5.31
최근 거래 시간
1
@
5.11
마지막 거래 시간
재정 규모
US$ 456,109
VWAP
5.1646
평균 볼륨(3m)
219,486
발행 주식
18,420,906
배당수익률
-
주가수익률
-5.35
주당순이익(EPS)
-0.95
매출
71.52M
순이익
-17.57M

OptimizeRx Corporation 정보

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution support patient adhere... OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution support patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement. 더 보기

섹터
Business Services, Nec
산업
Business Services, Nec
웹사이트
본부
Las Vegas, Nevada, USA
설립됨
-
OptimizeRx Corporation is listed in the Business Services sector of the 나스닥 with ticker OPRX. The last closing price for OptimizeRx was US$5.31. Over the last year, OptimizeRx shares have traded in a share price range of US$ 3.78 to US$ 16.645.

OptimizeRx currently has 18,420,906 shares in issue. The market capitalisation of OptimizeRx is US$97.82 million. OptimizeRx has a price to earnings ratio (PE ratio) of -5.35.

OPRX 최신 뉴스

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-1.47-22.34042553196.586.69995.11025365.83167971CS
4-0.35-6.410256410265.466.775.11200115.89091576CS
12-0.09-1.730769230775.26.774.182194865.30792109CS
26-3.57-41.12903225818.688.683.782170485.51704314CS
52-9.93-66.023936170215.0416.6453.781744777.67027054CS
156-39.62-88.575899843544.7346.01613.7818320714.3712087CS
260-5.93-53.713768115911.0499.17773.7819288828.93630591CS

OPRX - Frequently Asked Questions (FAQ)

What is the current OptimizeRx share price?
The current share price of OptimizeRx is US$ 5.11
How many OptimizeRx shares are in issue?
OptimizeRx has 18,420,906 shares in issue
What is the market cap of OptimizeRx?
The market capitalisation of OptimizeRx is USD 97.82M
What is the 1 year trading range for OptimizeRx share price?
OptimizeRx has traded in the range of US$ 3.78 to US$ 16.645 during the past year
What is the PE ratio of OptimizeRx?
The price to earnings ratio of OptimizeRx is -5.35
What is the cash to sales ratio of OptimizeRx?
The cash to sales ratio of OptimizeRx is 1.31
What is the reporting currency for OptimizeRx?
OptimizeRx reports financial results in USD
What is the latest annual turnover for OptimizeRx?
The latest annual turnover of OptimizeRx is USD 71.52M
What is the latest annual profit for OptimizeRx?
The latest annual profit of OptimizeRx is USD -17.57M
What is the registered address of OptimizeRx?
The registered address for OptimizeRx is 4955 S. DURANGO DR, SUITE 165, LAS VEGAS, NEVADA, 89113
What is the OptimizeRx website address?
The website address for OptimizeRx is www.optimizerx.com
Which industry sector does OptimizeRx operate in?
OptimizeRx operates in the BUSINESS SERVICES, NEC sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ENVBEnveric Biosciences Inc
US$ 2.27
(92.37%)
135.42M
PITAHeramba Electric PLC
US$ 0.694
(88.08%)
100.75M
PRCHPorch Group Inc
US$ 6.60
(74.14%)
32.03M
MULNMullen Automotive Inc
US$ 4.035
(70.97%)
94.61M
RENBRenovaro Inc
US$ 1.19
(53.95%)
31.84M
VEROVenus Concept Inc
US$ 0.326949
(-39.45%)
1.97M
SNDKSanDisk Corporation
US$ 46.705
(-38.69%)
8.41M
FLYWFlywire Corporation
US$ 11.045
(-37.39%)
25.43M
ILAGIntelligent Living Application Group Inc
US$ 0.5444
(-33.61%)
478.24k
ONVOOrganovo Holdings Inc
US$ 0.8499
(-33.08%)
50.73M
NVDANVIDIA Corporation
US$ 131.28
(3.67%)
332.46M
LCIDLucid Group Inc
US$ 2.255
(-13.60%)
160.81M
TRNRInteractive Strength Inc
US$ 1.2401
(30.58%)
158.83M
SMCISuper Micro Computer Inc
US$ 51.08
(12.17%)
144.52M
ENVBEnveric Biosciences Inc
US$ 2.27
(92.37%)
135.42M

OPRX Discussion

게시물 보기
4retire 4retire 3 월 전
It’s a crying shame that management continues to spend, trying to build the business, and has absolutely no regard as to turning profitable and creating shareholder value. Just read a report on Simply Wall St. that predicts OPRX will remain unprofitable for three more years. The BOD needs to address this and get the CEO under control. This is a public company, not a private one.
👍️0
4retire 4retire 3 월 전
OPRX shareholders paying the price for the horrific management team currently running this into the ground. The BOD should be taking action on the current CEO.
👍️0
4retire 4retire 3 월 전
Another quarter of increased revenues with deplorable losses due to huge increase in operating expenses. I believe we have extremely poor management concerning the quest for profitability and increasing shareholder value. Astronomical write off in “good will”. I hate to but I’m giving up on OPRX. Terrible disappointment.
👍️0
4retire 4retire 7 월 전
Interesting CC yesterday. Once again they missed hitting the top line number, but a customer delay was referenced for that happening. To hit full year numbers they will have to do $64 million in second half of the year.

If that’s accomplished, I would hope profitability would be achieved. Been here a very long time waiting for the company to turn profitable
👍️0
4retire 4retire 2 년 전
This has to be the most foolish management ever. Buying back stocks during the quarter at $14 plus when you know the 10Q results were going to be lousy is just foolish. Could have bought 40% more after latest results. Didn’t they realize the quarterly results were not going to be absorbed well by their current shareholders? Where’s the intelligence?
👍️0
4retire 4retire 2 년 전
Another disappointment .They should wait until after quarterly reports to buy back stocks. Lots for sale then. Tired of disappointing results, quarter after quarter
👍️0
4retire 4retire 2 년 전
Just read where OPRX’s board unanimously approved a $15 million share buyback This is on top of the approximately $2 million buyback last fiscal year. It goes without saying that the management and board have no regard as to having a profitable company for their shareholders (current and future).. I can foresee the future…..as cash is whittled down through increases in costs, and now share buybacks, there will be a need for raising capital by a new public offering which will increase share outflow. Unfathomable!!!
👍️0
4retire 4retire 2 년 전
Just a few days past the 10K and I am now realizing management’s plan. Drive the pps down through lack of execution, over spending and ineptitude. That way they can buy back more shares for a smaller hit to the bottom line. Sarcasm magnified.

Horrible performance for a reportedly best of breed solution to a potential $10 billion market. Shameful.
👍️0
4retire 4retire 2 년 전
On another note, OPRX was recently removed from the S&P's 600 small cap stocks. Insignificant? I think so. I do remember the press release when it originally made that list however.
👍️0
4retire 4retire 2 년 전
Just listened to the OPRX conference call. They've showed decreases in revenues the last two quarters and are forecasting another drop in Q1's (about 11%) revenue. They are forecasting an increase of over 10% growth for this year. That means robust revenues are to be recognized in Q's 2, 3 and 4.

Keep in mind OptimizerX is targeting a $10 billion market. If we, in fact, have the best solution for a customer's ROI, it has to be realized in increased volumes and profits someday. The pace, or lack thereof, is maddening.

Of particular concern is the increased costs that continue to damage the profitability of this company. The COO said costs will increase in Q1/23 as revenues are forecasted to shrink in that quarter . Noteworthy is that they are doing buybacks of their stock. They reduced the share count from barely over 18 million to just above 17 million. This was a 7% reduction but cost the bottom line over $1.2 million. One has to ask why this is deemed significant when the stock has lost so much value over the last 12 months. Wouldn't a profitable OPRX seem more desirable to own than one with a million less shares? This puzzles me.
👍️0
4retire 4retire 3 년 전
Found out what happened. Sales peaked while operating expenses soared. Horrible mismanagement of company’s financials. Keep adding costs and continue to be building infrastructure to handle the big boom, if and whenever it comes.

Too long in the game to continue to act like a start up company. Very disappointing
👍️0
4retire 4retire 3 년 전
What in the heck happened to OPRX today? Lost 20% of value and I can’t find any news
👍️0
4retire 4retire 3 년 전
OPRX will be releasing first quarter report at 1:30 PT on Wednesday, May 4th
👍️0
4retire 4retire 3 년 전
Had a good quarter. Over $20 million in sales. Expecting ‘22 to be between $80 & $85 million. Gross profit percentage is also increasing
👍️0
4retire 4retire 3 년 전
I am starting to see PR's issued by OPRX not appearing on InvestorsHub's website. One was issued on 2/22 and a pre-announcement of earnings was seen on my Iphone today. Supposedly Q4 and year end results are out tomorrow. Sales for Q4 is reported to be upwards of $20 million with only a $600,000 net profit. Growing sales without sustainable profits is a horrible formula....one that is unsustainable IMO.
👍️0
4retire 4retire 3 년 전
It's a travesty that a near miss on a quarterly report would cause a 30% drop in the value of this company. It was either highly inflated or people are losing patience in the management to control costs while following their growth strategies.

For example, was there a need to add 32 more sales/marketing personnel this past quarter? There probably was. But, as such, they cannot have less than a stellar fourth quarter in sales and increased profitability. Growth with the absence of profit is dooming to any equity.
👍️0
4retire 4retire 3 년 전
Nice growth on the quarterly report. Unfortunately there was huge growth in expenses as well. Would be nice if we could keep expenses level while growing the top and bottom line. Sales were excellent. They keep gearing up for their next expected growth cycle but, in doing so, eliminate robust profitability. Time will tell. In the meantime we’re seeing an 18% decrease in pps since yesterday with today’s activity including after hours
👍️0
4retire 4retire 3 년 전
What an amazing run this stock is having. They reached profitability last quarter and that included a very hefty rise in infrastructure expense as they built out the foundation for increased market share while increasing revenues and profits. This upcoming quarterly report could be the catalyst for further advancement in price per share growth.
👍️0
Liam859 Liam859 3 년 전
This stock just goes straight up I think the P.E. Ratio is like 2000 times sales. Absolutely gonna short on next correction $93
👍️0
4retire 4retire 4 년 전
Profitability!!! Yes. Going to be a great ride going forward
👍️0
4retire 4retire 4 년 전
Really looking forward to tomorrow's quarterly report.
👍️0
4retire 4retire 4 년 전
What a great year for OPRX! Pipeline is ROBUST. Great stock
👍️0
whytestocks whytestocks 4 년 전
JUST IN: $OPRX OptimizeRx Expects Record Revenue Exceeding $10.0 Million in Q3 2020, up 100%

ROCHESTER, Mich., Oct. 13, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported preliminary unaudited revenue for its third quarter ended September 30, 2020. Revenue f...

Find out more OPRX - OptimizeRx Expects Record Revenue Exceeding $10.0 Million in Q3 2020, up 100%
👍️0
whytestocks whytestocks 5 년 전
News: $OPRX OptimizeRx Sales Momentum Continues with Two New Enterprise-level Engagements Added to its Digital Health Platform

ROCHESTER, Mich., July 07, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has secured two new SaaS-based enterprise-level engagements that provide the full spectrum of access to the company&#x...

Read the whole news OPRX - OptimizeRx Sales Momentum Continues with Two New Enterprise-level Engagements Added to its Digital Health Platform
👍️0
4retire 4retire 5 년 전
I'm surprised no one has posted about the lousy quarter/year that OPRX disclosed. This was prefaced by an article saying how the pipeline is doing well. Expenses grew dramatically and the sales grew at a slower pace. They've ramped up for ???????
👍️0
whytestocks whytestocks 5 년 전
News: $OPRX OptimizeRx Sales Pipeline Up 79% to $84 Million in 2019; Company Reiterates Strong Q4 and 2020 Outlook

ROCHESTER, Mich., Dec. 09, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health solutions for pharmaceutical companies, payers, medtech and medical associations, reported its sales pipeline, which is comprised of outstanding request for proposal...

Got this from OPRX - OptimizeRx Sales Pipeline Up 79% to $84 Million in 2019; Company Reiterates Strong Q4 and 2020 Outlook
👍️0
whytestocks whytestocks 6 년 전
News: $OPRX OptimizeRx Sets First Quarter 2019 Conference Call for Wednesday, May 8, 2019 at 4:30 p.m. ET

ROCHESTER, Mich., April 26, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, will hold a conference call on Wednesday, May 8, 2019 at 4:30 p.m. Eastern time to discuss results for the first quarter ...

Read the whole news https://marketwirenews.com/news-releases/optimizerx-sets-first-quarter-2019-conference-call-for-wednesday-may-8-2019-at-4-30-p-m-et-8066294.html
👍️0
4retire 4retire 6 년 전
Tough to see over a 13% drop on someone selling just a few thousand shares.
👍️0
pearsby09 pearsby09 6 년 전
HLYK could very well be the next OPRX. Same concept in Health Care (Trillion Dollar Market). Already over 2 Hundred Thousand Prescribers!

CEO, Dr. Dent already has proven Himself with Neogenics Inc.


Only .24 cents per share, High insider holdings and low float...Do your Own DD!

BTW, Congrats on this stock!
👍️0
COLD COLD 6 년 전
Only a few us have been paying attention to this stock. Unbelievable how under the radar this stock is. Total shares 11 million? Stock has more than tripled in a year. Buy out on the horizon? Wow...just wow.
👍️0
4retire 4retire 6 년 전
That's very interesting. Change of control bonus.......means a sale down the road......interesting indeed.
👍️0
gjervis gjervis 6 년 전
$OPRX

Their 8K says alot!! Change of control bonus!! what are they hinting at?

“As a universal and new change, the Company’s bonus plan was amended to include a change of control bonus ranging from $0 to up to $750,000, depending on the transaction price, for each of these four executive officers, if a change of control transaction occurs in either 2018 or 2019.”
👍️0
4retire 4retire 6 년 전
This is huge!


OptimizeRx Launches ROI Guarantee to Pharmaceutical Manufacturers







👍️0
4retire 4retire 7 년 전
Good quarter. We are now profitable for the quarter with growth in revenue and gross margin increases for the future. The future is looking good.
👍️0
Renee Renee 7 년 전
I see the quote box and historical volumes are working perfectly. Thanks to Admins Tisha and Warren.

My part was itsy bitsy,
👍️0
4retire 4retire 7 년 전
Thank you for addressing this.
👍️0
Renee Renee 7 년 전
ADMIN is working on the quote box and historical data (volumes/price). It probably won't be fixed until after the market opens on monday but be assured the problem will be corrected.

👍️0
4retire 4retire 7 년 전
I have emailed IHUB on the erroneous reporting (or lack of)on OPRX. As you know, they have not updated the price/volume in days. my response was that I have to be the moderator, or assistant moderator of the OPRX message board to request to have this corrected.

I was somewhat surprised by this......well, maybe not.

👍️0
Renee Renee 7 년 전
OPRX moved from the OTC to the Nasdaq:

http://otce.finra.org/DLDeletions
👍️0
4retire 4retire 7 년 전
This should be a great move! Part of the release:

ROCHESTER, Mich., June 19, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading global provider of digital health messaging for the pharmaceutical industry, has uplisted to the Nasdaq Capital Market, with its common stock to commence trading on the exchange beginning Friday, June 22, 2018 under the symbol, “OPRX.”


“Joining the Nasdaq Capital Market represents another major milestone for OptimizeRx, following a number of significant events over the last few months,” said company CEO, William Febbo. “After announcing the expansion of our digital health messaging services beyond the ambulatory setting and into hospitals, we reported our sixth consecutive quarter of record revenue. This was soon followed by our first international expansion into Europe with a major partner, building upon our reach to more than half of the ambulatory patient market in the U.S.

“As we continue to demonstrate high ROI from the marketing spend of our pharma clients and strengthen our network of EHR partners, we expect our Nasdaq listing to further elevate our corporate profile, enhance liquidity for our investors, and broaden our shareholder base.”
👍️0
$Pistol Pete$ $Pistol Pete$ 7 년 전
$OPRX https://www.otcmarkets.com/stock/OPRX/news/OptimizeRx-Uplists-to-the-Nasdaq-Capital-Market?id=195923
👍️0
TenKay TenKay 7 년 전
OPRX Reverse split, 1 for 3.

http://otce.finra.org/DailyList
👍️0
4retire 4retire 7 년 전
I know. Congrats to all of us longs. They expect profitability soon and once the Nasdaq listing hits, institutions will notice this little gem. I never publicly predict, but this will be a 10 bagger eventually.......and not too far in the distant future (IMO).
My CRC is hitting. What a GREAT COUNTRY!
👍️0
gjervis gjervis 7 년 전
Capital raise at $1.80 and the stock does not even budge from plus $2.00. then we uplist to the NASDAQ, patience is paying off for this multibagger.
👍️0
4retire 4retire 7 년 전
Quarterly numbers look great. Impressive results in revenues, gross profit and future outlook. Nasdaq on the horizon.

👍️0
COLD COLD 7 년 전
Persby - I agree. Quarterly numbers and conference call will be very interesting. NASDAQ around the corner?
👍️0
gjervis gjervis 7 년 전
$OPRX Was only a matter of time before Mr. Market noticed this company
👍️0
pearsby09 pearsby09 7 년 전
COLD. Check out MGX minerals. A huge Lithium/Magnesium and waste water play. They Have a breakthrough Lithium extraction play. Extraction in days vs. many months. Primed to garner revenues shortly. Please do your DD and IMO only. GLTY
👍️0
COLD COLD 7 년 전
AGREED!!! RQHTF is taking off like a rocket ship. I'm not a pumper. Take a look. GLTU.
👍️0
pearsby09 pearsby09 7 년 전
We currently have huge resistance at 1.60 pps. If we can break that resistance, watch out above!
👍️0

최근 히스토리

Delayed Upgrade Clock